Insider · CIK 0002062582
Kevin Charles Roe
Files at YCBD (cbdMD, Inc.). First filing -, latest -.
In brief
Kevin Charles Roe files SEC Form 4 as director at YCBD (cbdMD, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kevin Charles Roe has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | YCBD cbdMD, Inc. | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 26,707 | Apr 16, 2026 |
| May 16, 2025 | YCBD cbdMD, Inc. | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 25,135 | May 20, 2025 |
| May 6, 2025 | YCBD cbdMD, Inc. | CConversion Common Stock | +23,563 | - | - | 23,563 | May 8, 2025 |
| May 6, 2025 | YCBD cbdMD, Inc. | CConversion 8% Series A Cumulative Convertible Preferred Stockderivative | -14,500 | - | - | 0 | May 8, 2025 |
Questions about Kevin Charles Roe
Answered from the filings on this page, as of the latest one.
Is Kevin Charles Roe buying or selling?
Kevin Charles Roe has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kevin Charles Roe's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin Charles Roe has 0.
Where does Kevin Charles Roe file Form 4?
Kevin Charles Roe has filed Form 4 at YCBD (cbdMD, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.